Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Gains from Investment Securities (2023 - 2025)

Upstream Bio (UPB) has 3 years of Gains from Investment Securities data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 65.14% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $2.2 million, down 65.14%, while the annual FY2024 figure was $6.5 million, 55.79% up from the prior year.
  • Gains from Investment Securities reached $2.2 million in Q3 2025 per UPB's latest filing, up from $6448.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $7.9 million in Q1 2025 and bottomed at -$1.6 million in Q4 2024.
  • Average Gains from Investment Securities over 3 years is $2.5 million, with a median of $1.1 million recorded in 2025.
  • Peak YoY movement for Gains from Investment Securities: tumbled 54166.67% in 2024, then tumbled 65.14% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $3000.0 in 2023, then crashed by 54166.67% to -$1.6 million in 2024, then soared by 234.08% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $2.2 million in Q3 2025, $6448.0 in Q2 2025, and $7.9 million in Q1 2025.